Clinical Trial of Levodopa/Carbidopa ( Sinemet) Therapy in Angel Man Syndrome

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

November 26, 2013

Primary Completion Date

February 1, 2019

Study Completion Date

February 1, 2019

Conditions
Angelman Syndrome
Interventions
DRUG

Levodopa

The target dose of Sinemet is 2-10 mg per kilogram per day of levodopa. The initial dose will be determined by your weight and age and will start at a low dosage level, 1 mg per kilogram per day. The dose will be re-evaluated after the first 2 weeks and may be adjusted at each visit depending on your response to the drug.

All Listed Sponsors
lead

Bennett Lavenstein

OTHER

NCT03235037 - Clinical Trial of Levodopa/Carbidopa ( Sinemet) Therapy in Angel Man Syndrome | Biotech Hunter | Biotech Hunter